Rudy Richardson

Personal Home Page

http://www.sph.umich.edu/iscr/faculty/profile.cfm?uniqname=rjrich

Articles in Scholarly Journals [Incomplete List]

  1. Modeling the Tertiary Structure of the Patatin Domain of Neuropathy Target Esterase
    The Protein Journal, vol. 26, no. 3, pp. 165–172, 2007
  2. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing
    Behavioural Brain Research, vol. 183, no. 2, pp. 161–168, 2007
  3. Multicultural tensions in the military? Evidence from the Netherlands armed forces
    International Journal of Intercultural Relations, vol. 31, no. 3, pp. 339–361, 2007
  4. Nanostructured Biosensor for Measuring Neuropathy Target Esterase Activity
    Analytical Chemistry, vol. 79, no. 14, pp. 5196–5203, 2007
  5. Mechanism of Aging of Mipafox-Inhibited Butyrylcholinesterase
    Chemical Research in Toxicology, vol. 20, no. 3, pp. 504–510, 2007
  6. Dose-Effect Analyses of Occupational Chlorpyrifos Exposure and Peripheral Nerve Electrophysiology
    Toxicological Sciences, vol. 97, no. 1, pp. 196–204, 2007
  7. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress
    Human & Experimental Toxicology, vol. 26, no. 4, pp. 273–282, 2007
  8. Abduction as the type of inference that characterizes the development of a grounded theory
    Qualitative Research, vol. 6, no. 4, pp. 497–513, 2006
  9. Chemical Research in Toxicology, vol. 19, no. 2, pp. 334–339, 2006
  10. Biomacromolecules, vol. 7, no. 12, pp. 3327–3335, 2006
  11. Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease
    Brain Research, vol. 1116, no. 1, pp. 177–186, 2006
  12. Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model
    Neuroscience Letters, vol. 373, no. 3, pp. 189–194, 2005
  13. Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos
    Muscle & Nerve, vol. 29, no. 5, pp. 677–686, 2004
  14. The Mipafox-Inhibited Catalytic Domain of Human Neuropathy Target Esterase Ages by Reversible Proton Loss
    Biochemistry, vol. 43, no. 12, pp. 3716–3722, 2004
  15. The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study
    Occupational and Environmental Medicine, vol. 61, no. 3, pp. 201–211, 2004
  16. The Effects of Occupational Exposure to Chlorpyrifos on the Neurologic Examination of Central Nervous System Function: A Prospective Cohort Study
    Journal of Occupational and Environmental Medicine, vol. 46, no. 4, pp. 367–378, 2004
  17. Relative Inhibitory Potencies of Chlorpyrifos Oxon, Chlorpyrifos Methyl Oxon, and Mipafox for Acetylcholinesterase Versus Neuropathy Target Esterase
    Journal of Toxicology and Environmental Health Part A, vol. 66, no. 12, pp. 1145–1157, 2003
  18. Quantitative Structure-Activity Relationships Predict the Delayed Neurotoxicity Potential of a Series of O -Alkyl- O -Methylchloroformimino Phenylphosphonates
    Journal of Toxicology and Environmental Health Part A, vol. 66, no. 7, pp. 611–625, 2003
  19. Biosensor Detection of Neuropathy Target Esterase in Whole Blood as a Biomarker of Exposure to Neuropathic Organophosphorus Compounds
    Journal of Toxicology and Environmental Health Part A, vol. 66, no. 7, pp. 599–610, 2003
  20. Chemical Research in Toxicology, vol. 16, no. 8, pp. 958–965, 2003
  21. Identification of Butyrylcholinesterase Adducts after Inhibition with Isomalathion Using Mass Spectrometry: Difference in Mechanism between (1R)- and (1S)-Stereoisomers
    Toxicology and Applied Pharmacology, vol. 176, no. 2, pp. 73–80, 2001
  22. Chemical Research in Toxicology, vol. 13, no. 12, pp. 1313–1320, 2000
  23. Kinetic Evidence for Different Mechanisms of Acetylcholinesterase Inhibition by (1R)- and (1S)-Stereoisomers of Isomalathion,
    Toxicology and Applied Pharmacology, vol. 155, no. 1, pp. 43–53, 1999
  24. Common Mechanism of Toxicity: A Case Study of Organophosphorus Pesticides,
    Toxicological Sciences, vol. 41, no. 1, pp. 8–20, 1998
  25. Inhibition of Neurotoxic Esterasein Vitroby Novel Carbamates
    Toxicology and Applied Pharmacology, vol. 143, no. 1, pp. 173–178, 1997
  26. POTENTIATION OF ORGANOPHOSPHORUS COMPOUND-INDUCED DELAYED NEUROTOXICITY (OPIDN) IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF THE ADULT HEN: DISTRIBUTION OF AXONAL LESIONS
    Journal of Toxicology and Environmental Health, Part A, vol. 51, no. 6, pp. 571–590, 1997
  27. Relative Potencies of the Four Stereoisomers of Isomalathion for Inhibition of Hen Brain Acetylcholinesterase and Neurotoxic Esterasein Vitro
    Toxicology and Applied Pharmacology, vol. 139, no. 2, pp. 342–348, 1996
  28. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: Application to assessment of neuropathic risk*
    Fundamental and Applied Toxicology, vol. 20, no. 3, pp. 273–279, 1993
  29. Chlorpyrifos: Assessment of Potential for Delayed Neurotoxicity by Repeated Dosing in Adult Hens with Monitoring of Brain Acetylcholinesterase, Brain and Lymphocyte Neurotoxic Esterase, and Plasma Butyrylcholinesterase Activities
    Fundamental and Applied Toxicology, vol. 21, no. 1, pp. 89–96, 1993
  30. Neurotoxic esterase: Characterization of the solubilized enzyme and the conditions for its solubilization from chicken brain microsomal membranes with ionic, zwitterionic, or nonionic detergents
    Biochemical Pharmacology, vol. 36, no. 9, pp. 1393–1399, 1987
  31. Kinetics of heat inactivation of phenyl valerate hydrolases from hen and rat brain
    Biochemical Pharmacology, vol. 36, no. 19, pp. 3181–3185, 1987
  32. Lymphocyte and brain neurotoxic esterase: Dose and time dependence of inhibition in the hen examined with three organophosphorus esters
    Toxicology and Applied Pharmacology, vol. 83, no. 1, pp. 1–9, 1986
  33. Solubilization of hen brain neurotoxic esterase in dimethylsulfoxide
    Biochemical and Biophysical Research Communications, vol. 132, no. 1, pp. 81–87, 1985
  34. Partial characterization of neurotoxic esterase of human placenta
    Toxicology Letters, vol. 15, no. 1, pp. 13–17, 1983
  35. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen,
    Biochemical Pharmacology, vol. 31, no. 6, pp. 1117–1121, 1982
  36. SUBCELLULAR DISTRIBUTION OF MARKER ENZYMES AND OF NEUROTOXIC ESTERASE IN ADULT HEN BRAIN
    Journal of Neurochemistry, vol. 32, no. 2, pp. 607–615, 1979